sec filing
GC
OTC · GCAN
The Greater Cannabis Company, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$1.60
Up+$0.00 (+0.00%)
Updated Oct 8, 2026, 10:19 AM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 54.92K
- P/E ratio
- -108.6
- Dividend yield
- 0.00%
- 52-week range
- $0.15 – $3.60
- Volume
- 13.37K
- Avg. volume
- 2.01K
Price performance · GCAN
GCAN price history
1M range · 3 trading sessions · Daily adjusted prices
Prices through Sep 16, 2026
GCAN closed at $2.35 after 3 trading sessions, up 27.03% for the selected period.
- Last close
- $2.35
- Period change
- +27.03%
- Period low
- $1.85
- Period high
- $2.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.999 | $2.499 | $1.60 | $2.35 | 13.37K |
| Sep 15, 2026 | $1.85 | $1.999 | $1.85 | $1.999 | 6.06K |
| Sep 9, 2026 | $1.8975 | $1.8975 | $1.85 | $1.85 | 181.8 |
Latest GCAN news
The latest Smart Investors Daily articles mentioning GCAN.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…